Untitled

122 CHARACTERISTICS OF BRAIN AND BEHAVIORSuzuki, M., Hagino, H., Nohara, S., Zhou, S. Y., Kawasaki, Y., Takahashi, T., et al. (2005).Male-specific volume expansion of the human hippocampus during adolescence. CerebralCortex, 15(2), 187–193.Talbot, K., Eidem, W. L., Tinsley, C. L., Benson, M. A., Thompson, E. W., Smith, R. J.,et al. (2004). Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampalformation in schizophrenia. Journal of Clinical Investigation, 113(9), 1353–1363.Tamminga, C. A., Thaker, G. K., Buchanan, R., Kirkpatrick, B., Alphs, L. D., Chase,T. N., et al. (1992). Limbic system abnormalities identified in schizophrenia usingpositron emission tomography with fluorodeoxyglucose and neocortical alterations withdeficit syndrome. Archives of General Psychiatry, 49(7), 522–530.Tarrant, C. J., & Jones, P. B. (1999). Precursors to schizophrenia: Do biological markershave specificity? Canadian Journal of Psychiatry, 44(4), 335–349.Thompson, P. M., Egbufoama, S., & Vawter, M. P. (2003). Snap-25 reduction in the hippocampusof patients with schizophrenia. Progress in Neuropsychopharmacology andBiological Psychiatry, 27(3), 411–417.Tibbo, P., Hanstock, C., Valiakalayil, A., & Allen, P. (2004). 3–T proton MRS investigationof glutamate and glutamine in adolescents at high genetic risk for schizophrenia.American Journal of Psychiatry, 161(6), 1116–1118.Traynelis, S. F., Hartley, M., & Heinemann, S. F. (1995). Control of proton sensitivity ofthe NMDA receptor by RNA splicing and polyamines. Science, 268(5212), 873–876.Tsai, M. T., Hung, C. C., Tsai, C. Y., Liu, M. Y., Su, Y. C., Chen, Y. H., et al. (2002).Mutation analysis of synapsin III gene in schizophrenia. American Journal of MedicalGenetics, 114(1), 79–83.Turetsky, B., Cowell, P. E., Gur, R. C., Grossman, R. I., Shtasel, D. L., & Gur, R. E. (1995).Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptomsand clinical subtype. Archives of General Psychiatry, 52(12), 1061–1070.Turetsky, B. I., Moberg, P. J., Roalf, D. R., Arnold, S. E., & Gur, R. E. (2003). Decrementsin volume of anterior ventromedial temporal lobe and olfactory dysfunction inschizophrenia. Archives of General Psychiatry, 60(12), 1193–1200.Ungless, M. A., Whistler, J. L., Malenka, R. C., & Bonci, A. (2001). Single cocaine exposurein vivo induces long-term potentiation in dopamine neurons. Nature, 411(6837),583–587.Vawter, M. P. (2000). Dysregulation of the neural cell adhesion molecule and neuropsychiatricdisorders. European Journal of Pharmacology, 405(1–3), 385–395.Vawter, M. P., Crook, J. M., Hyde, T. M., Kleinman, J. E., Weinberger, D. R., Becker,K. G., et al. (2002a). Microarray analysis of gene expression in the prefrontal cortex inschizophrenia: A preliminary study. Schizophrenia Research, 58(1), 11–20.Vawter, M. P., Thatcher, L., Usen, N., Hyde, T. M., Kleinman, J. E., & Freed, W. J. (2002b).Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.Molecular Psychiatry, 7(6), 571–578.Vawter, M. P., Usen, N., Thatcher, L., Ladenheim, B., Zhang, P., VanderPutten, D. M.,et al. (2001). Characterization of human cleaved n-cam and association with schizophrenia.Experimental Neurology, 172(1), 29–46.Veldic, M., Caruncho, H. J., Liu, W. S., Davis, J., Satta, R., Grayson, D. R., et al. (2004).DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalicgabaergic interneurons of schizophrenia brains. Proceedings of the National Academyof the Sciences of USA, 101(1), 348–353.Veldic, M., Guidotti, A., Maloku, E., Davis, J. M., & Costa, E. (2005). In psychosis, cor-